Impact of OSA on Biological Markers in Morbid Obesity and Metabolic Syndrome | Zendy

Neus Salord | Zendy; Mercè Gasa | Zendy; Mercedes Mayos | Zendy; Ana Maria Fortuna-Gutiérrez | Zendy; Josep M. Montserrat | Zendy; Manuel SánchezdelaTorre | Zendy; Antònia Barceló | Zendy; Ferrán Barbé | Zendy; Núria Vilarrasa | Zendy; Carmen Monasterio | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of OSA on Biological Markers in Morbid Obesity and Metabolic Syndrome

Author(s) -

Neus Salord,

Mercè Gasa,

Mercedes Mayos,

Ana Maria Fortuna-Gutiérrez,

Josep M. Montserrat,

Manuel SánchezdelaTorre,

Antònia Barceló,

Ferrán Barbé,

Núria Vilarrasa,

Carmen Monasterio

Publication year - 2014

Publication title -

journal of clinical sleep medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.529

H-Index - 92

eISSN - 1550-9397

pISSN - 1550-9389

DOI - 10.5664/jcsm.3524

Subject(s) - medicine , adipokine , adiponectin , obstructive sleep apnea , metabolic syndrome , body mass index , chemerin , endocrinology , obesity , leptin , polysomnography , population , insulin resistance , apnea , environmental health

There is compelling evidence that obstructive sleep apnoea (OSA) can affect metabolic syndrome (MetS) and cardiovascular risk, but the intermediate mechanisms through which it occurs have not been well defined. We explored the impact of OSA in morbidly obese patients with MetS on adipokines, pro-inflammatory markers, endothelial dysfunction, and atherosclerosis markers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research